Shareholders meeting

September 25, 2026 BSE Limited National Stock Exchange of India Ltd., Department of Corporate Relationship Department of Corporate Services 1st Floor, New Trade Ring, Rotunda Building Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers C-1, Block G, Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (E), Mumbai – 400 051 Scrip Code: 524742 S c r i p C o d e : C A P L I P O I N T . Dear Sir/Madam, Sub: Proceedings of the Thirty Fifth Annual General Meeting of the company held on Friday, September 25, 2026. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the brief proceedings of the 35th Annual General Meeting of the Company held on Friday, September 25, 2026, at 10.00 A.M. (IST), through Video Conferencing/Other Audio Visual Means. The details of the consolidated voting results of both the remote e-voting and e-voting during the AGM on all the resolutions will be filed separately, in the format prescribed under Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your kind information and records. Thanking You, Sincerely yours, For Caplin Point Laboratories Limited Venkatram G General Counsel & Company Secretary Membership No A23989 Summary of the proceedings of the 35th Annual General Meeting The 35th Annual General Meeting (AGM) of the Members of Caplin Point Laboratories Limited (“the Company”) was held on Friday, September 25, 2026, at 10.00 A.M through Video Conferencing/ Other Audio Visual Means (“VC/OAVM”), as per the guidelines issued by the Ministry of Corporate Affairs (“MCA”) through various Circulars and applicable provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). The Company Secretary welcomed the shareholders to the 35th AGM and introduced the Directors, Key Managerial Personnel and other invitees who were present as part of the panel. All the Directors, except Mr. Ashok Partheeban, were present at the meeting. The Company Secretary informed the members about the availability of the requisite registers, certificates and disclosures for inspection by the members in accordance with the procedure mentioned in the Notice of the AGM. He then requested the Chairman, Mr. C. C. Paarthipan, to initiate the proceedings. The Chairman then confirmed the presence of requisite quorum and called the Meeting to order. He apprised the shareholders about the appointment of Mr. Ashok Partheeban and Mr. Vivek Partheeban as Directors and Vice-Chairmen, and Dr. K. C. John and Ms. Susan Mathew as Non- Executive Independent Directors, as approved by the shareholders through Postal Ballot on January 31, 2026. He further informed the shareholders about the proposed appointment of Mr. D. Muralidharan as Whole-Time Director for two years, and the proposed re-a ppointment of Dr. Sridhar Ga nesan as Managing Director for a further period of two years. Thereafter, Chairman delivered his speech on the performance of the Company, other highlights/developments during FY 2025-26 and the way forward. Chairman then invited Dr. Sridhar Ganesan, Managing Director, to deliver his speech and make a presentation on the performance of the Company. Dr. Sridhar Ganesan made his speech and highlighted the performance of the Company and its Subsidiaries. Thereafter, Chairman invited Mr. Vivek Partheeban to deliver his speech on the Company’s Regulated Markets business. Chairman then invited Mr. D. Muralidharan, Whole-Time Director & Chief Financial Officer, to brief the members on the financial performance of the Company. Then, the Chairman invited the other Directors to share their views on the Company’s performance, following which the Directors delivered their respective speeches. Subsequently, the Chairman invited the Company Secretary to complete other statutory formalities. With the permission of the members present, the Company Secretary took the audited standalone and consolidated financial statements for the year ended March 31, 2026, and the Annual Report for the year ended March 31, 2026, as read. The Company Secretary then read out the list of Ordinary and Special Resolutions as set out in the Notice convening the AGM, which were proposed for consideration at the AGM. Thereafter, he informed the members that the Statutory Audit Report and Secretarial Audit Report were free from qualifications and thus, in terms of provisions of Section 145 of the Companies Act, 2013 the same can be taken as read. The Company Secretary explained briefly about the e-voting procedures and informed that the members who were present at the AGM and who had not cast their votes were provided an opportunity to cast their votes electronically within 15 minutes from the conclusion of the meeting. Then, he informed that out of three members who had registered as speaker shareholders, two were present. However, only one shareholder raised his queries, which were suitably addressed by the Company Secretary. Thereafter, Chairman invited Dr. Sridhar Ganesan, Managing Director to conclude the meeting with vote of thanks. Accordingly, Dr. Sridhar Ganesan informed the members that the results of remote e-voting /e- voting at the AGM will be consolidated and announced within 2 working days to the Stock Exchanges and posted on the website of the company. He thanked all the shareholders, employees, partners, suppliers, dealers, customers and other stakeholders for their continued faith in the Company and declared the meeting closed. The meeting concluded at 10.51 A.M. The following items of business, as per the Notice of 35th AGM, were subject to voting through electronic means (Remote e-Voting between September 22, 2026, and September 24, 2026, and e-Voting at the AGM): S. No Subject matter of Resolution Type of Resolution Ordinary business 1. Adoption of Financial Statements Ordinary 2. Declaration of Final Dividend and Ratification of Interim Dividend Ordinary 3. Retirement by rotation of Dr. Sridhar Ganesan (DIN: 06819026) and Ordinary consideration of his re-appointment Special Business 4. Re-appointment of Dr. Sridhar Ganesan (DIN: 06819026) as the Special Managing Director of the Company 5. Continuation of Mr. C. C. Paarthipan (DIN: 01218784) as the Special Chairman and Non-Executive, Non-Independent Director of the Company 6. Appointment of Mr. D Muralidharan (DIN: 08301904) as a Whole Special Time Director of the Company. ****************